Morgan Stanley Lowers Lincoln National Target to $40, Keeps Overweight
Morgan Stanley lowered its price target on Lincoln National (LNC) to $40 from $43, while keeping an Overweight rating. The stock still offers 30% upside and is among the best insurance stocks to buy after Q1 earnings.
Key Numbers
Morgan Stanley lowered its price target on Lincoln National Corporation (NYSE:LNC) to $40 from $43, while maintaining an Overweight rating on the shares. The adjustment was made on May 21, 2026, following the company's first-quarter earnings release.
Rating Change
- Previous Target: $43
- New Target: $40
- Rating: Overweight (unchanged)
Analyst Rationale
The analyst sees an upside potential of 30.06%, which keeps LNC among the top 10 insurance stocks to buy after Q1 results. Despite the target cut, the positive outlook reflects confidence in the company's long-term performance.
Context
No other analyst revisions were mentioned. The stock's recent performance was not detailed. Lincoln National operates in the life insurance and retirement sectors.
What to Make of It
The target reduction with a maintained Overweight rating suggests near-term headwinds but long-term value. Investors should monitor company performance and sector trends.
Frequently Asked Questions
Found this useful? Share it